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Methods: We studied 21 patients with EB,
16 asthmatic patients and 12 healthy sub-
jects. We analyzed EP2 and EP4 receptor
expression by Real-Time PCR and protein
expression by confocal microscopy and
ﬂow cytometry in induced sputum and
peripheral blood eosinophils. Moreover, we
tested the PGE2 effect on eosinophilic
apoptosis and bronchial smooth muscle
cells (BSMC) proliferation.
Results: Patients with EB showed higher
mRNA expression levels of EP2 (1.8-fold
and 2.03-fold higher) and EP4 (1.2-fold and
5.43-fold increase) in sputum cells and
peripheral blood eosinophils than asthmatic
patients, the differences were statistically
signiﬁcant in EP2 sputum samples and EP4
peripheral blood eosinophils (P < 0.05).
We assessed surface expression of EP2 and
EP4 on peripheral blood eosinophils by
confocal microscopy. An elevated expres-
sion of these receptors in eosinophils of EB
patients with respect to asthmatic patients
were obtained by ﬂow cytometry. Other-
wise, an increase of eosinophilic apoptosis
with sputum supernatants of EB patients
was observed in comparison with eosinophil
cultures with asthmatic patients sputum su-
pernatants (P < 0.05). When we evaluated
the effects of PGE2 in BSMC proliferation,
we observed that EB sputum supernatants
signiﬁcantly increased the percentage of
inhibition of BSMC proliferation as com-
pared with asthmatic sputum supernatants
(60.33% versus 48.92%; P < 0.05).
Conclusions: PGE2 acts through EP2 and
EP4 receptors in sputum and peripheral
blood eosinophils in eosinophilic bronchi-
tis. PGE2 is able to enhance eosinophilic
apoptosis which may decrease eosinophilic
inﬁltration and inﬂammation in eosino-
philic bronchitis. Furthermore, PGE2 may
inhibit bronchial smooth muscle cell prolif-
eration reducing smooth muscle hyperpla-
sia and preventing airﬂow obstruction.
These results suggest that PGE2 could
act like a novel therapeutic strategy in
eosinophilic bronchitis, asthma and others
inﬂammatory respiratory diseases.
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Background: Allergic asthma is character-
ized among others by IgE- and eosino-
philia-associated lung inﬂammation. T cells
plays a critical role in this process, leading
to the concept that allergic asthma is a
disease of immune dysregulation. Naı¨ve
T cells differentiate to subsets of T helper
(Th) cells regulated by speciﬁc transcrip-
tion factors such as T-bet/Th1, GATA-3/
Th2 and Foxp3/T regulatory cells (Tregs).
Recent reports suggest an inter-regulation
among them; emphasizing the need to
study the entire population. In this context,
our aim was to investigate the allergen
induced accumulation of all three subsets
in different parts of the inﬂamed lung
during allergic inﬂammation.
Methods: C57BL/6 mice were sensitized to
ovalbumin (OVA) followed by exposure to
OVA or PBS. Lung tissue was collected
24 h after the ﬁnal exposure. May-Gru¨n-
wald-Giemsa stained cytospin preparations
of lung cells was used to evaluate num-
ber of eosinophils. Number of T-bet+,
GATA-3+ and Foxp3+ cells per square
millimeter (mm2) was evaluated in the peri-
bronchial, perivascular and alveolar tissue
sections using immunohistochemistry.
Results: As expected, the mice acquired a
signiﬁcant lung eosinophilia after OVA
exposure (OVA/PBS; 55.78/3.10 · 106/ml;
P < 0.001) which was accompanied by a
signiﬁcant accumulation of T-bet+,
GATA-3 + and Foxp3 + peribronchially
(OVA/PBS; 0.21/0.02, 0.22/0.06, 0.27/0.04
mean cell number/mm2 respectively;
P < 0.01) as well as in the alveolar space
(OVA/PBS; 0.52/0.06, 0.21/0.01 and 0.21/
0.04 mean cell number/mm2 respectively;
P < 0.01). However, only GATA-3+ and
Foxp3+ cells were signiﬁcantly increased
perivascularly after OVA exposure (OVA/
PBS; 0.53/0.03 and 0.71/0.09 mean cell
number/mm2; P > 0.01).
Conclusion: Our data show that allergen
exposure result in an equal increased accu-
mulation of Th1, Th2 and Treg cells in
peribronchial tissue and also an increase in
the perivascular lung tissue, but here with
a dominance of Th1. Finally, perivascular-
ly only Th2 and Treg cells increase. Our
data argue that during allergic lung inﬂam-
mation we have an extended network of
effectors T cells that can have the capacity
to counterregulate each other and other
inﬂammatory cells.
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Background: CD86 is a well-known
costimulatory molecule in its interaction
with CD28 and/or CTLA present on T
cells, and is essential for full activation of
naı¨ve T-cell and differentiation. Usually
the B7 molecules are expressed mainly on
APCs and B cells and in speciﬁc conditions
on others activated cells.
Objective: To evaluate the expression of
CD86 on CD4+ cells during an allergic
IgE reaction induced on an experimental
murine model, based on a relevant human
allergen.
Methods: Induction of systemic allergic
response was achieved by three subcutane-
ous administrations of Parietaria judaica
(Pj) extract (Bial-Aristegui, Spain) in
27 inbreed male BALB/c mice. Allergic
reaction was triggered by ultrasonic nebuli-
zation of a 50% Pj solution for 5 min in a
glass camera. Different study groups of
mice were established according to the
elapsed time after challenge: 60 min (I),
120 min (II), and 360 min (III) respec-
tively. Control groups included 5 non-sen-
sitized (N) and 6 sensitized mice (A). After
sacriﬁce, blood was collected by intracar-
diac puncture. The study of the expression
of CD86 and CD25 (BD Biosciences,
USA) on CD4+ cells present on peripheral
mononuclear cells was performed by ﬂow
cytometry on a FACScan (Becton Dickin-
son, San Jose, CA), and the results
expressed in percentage of total CD4+
cells. Statistic analysis was performed using
One-Way ANOVA and Tuckey tests.
Results: Our results showed no differences
for the total number of CD4+ cells on
peripheral blood for the distinct groups:
N = 81.66 ± 6.5%; A = 81.66 ± 1.63%;
I = 82.33 ± 2.29%; II=82.33 ± 3.42%;
III=80.55 ± 3.39%. The inhalation of
speciﬁc allergen induced an increase in
CD4+ CD86+ expression compared to
control groups: N = 12.66 ± 0.57%;
A = 12.66 ± 3.88%; I = 17.33 ± 3.96%;
II=18.77 ± 5.86%; III=21.55 ± 11.01%
(P < 0.05). We also conﬁrmed that all the
CD4+ cells that expressed CD86 were acti-
vated cells (CD25+).
Conclusions: Our results conﬁrmed that a
subset of CD4+ cells on peripheral blood
also expressed CD86. During speciﬁc aller-
gic reaction there was a rapid increase of
CD86 T cells in the ﬁrst 60 min after chal-
lenge, with a slight increase at the 4th hour
after allergen exposure. All these cells were
activated (CD25+). These data suggest
that these cells could be relevant in IgE
mediated allergic reaction possibly by an
autocrine costimulation via CD28/CTLA
activation pathway.
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